Kekst CNC is handling media for Avista Capital Partners as it acquires Taconic Biosciences, the global leader in the production of genetically engineered rats and mice.
Founded in 1952, Rensselaer, NY-based Taconic ships its rodents worldwide for use in drug discovery and scientific research. It counts 40 of the top 50 pharmaceutical companies as clients.
Avista Capital Partners, a private equity firm, specializes in the healthcare sector. It has more than $8B invested in more than 40 companies.
Rob Girardi, Avista partner said Taconic is poised to continue its growth trajectory in the genetically engineered market due to its “reputation for high-touch consultative services, diversity of high-quality models and proven track record of innovation.”
Kekst CNC’s Daniel Yunger and Hallie Wolff are working the deal.
Publicis Groupe owns Kekst CNC.